Company Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.
The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems.
It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching.
The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.
DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
| Country | United States |
| IPO Date | Mar 14, 2016 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 276 |
| CEO | Erez Raphael |
Contact Details
Address: 18 West 18th Street New York, New York United States | |
| Website | https://www.mydario.com |
Stock Details
| Ticker Symbol | DRIO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001533998 |
| CUSIP Number | 23725P209 |
| ISIN Number | US23725P2092 |
| Employer ID | 45-2973162 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Erez Raphael | Chief Executive Officer & Director |
| Limor Drezner | Chief People Officer |
| Tomer Ben-Kiki | Chief Technology Officer |
| Zvi Ben David CPA | Chief Financial Officer, Treasurer & Secretary |
| Claudia Levi | Content & Communications Manager |
| Dov Oppenheim | Co-Founder & Production Chief |
| Jean Christophe Muyl | Head of Commercialization North America |
| Josh Fischer | Senior Vice President of Operations & Compliance |
| Kat Parrella | Investor Relations Manager |
| Mona Dean | Chief Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 14, 2024 | 4 | Filing |
| Nov 07, 2024 | 10-Q | Quarterly Report |
| Oct 29, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 24, 2024 | DEF 14A | Filing |
| Sep 20, 2024 | 8-K | Current Report |
| Sep 13, 2024 | 8-K | Current Report |
| Sep 12, 2024 | 4 | Filing |
| Sep 10, 2024 | 4 | Filing |
| Aug 28, 2024 | 4 | Filing |